NCT01390896View on ClinicalTrials.gov

Special Drug Use Investigation for ARIXTRA (Fondaparinux) Abdominal General Surgery

CompletedOBSERVATIONAL

Enrollment

329

Participants

Timeline

Start Date

September 30, 2009

Primary Completion Date

January 31, 2013

Study Completion Date

January 31, 2013

Conditions

Cardiovascular Disease

Interventions

DRUG

Fondaparinux Sodium

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY